(Q36490755)

14 August 2017

1 reference

title

Induction of tumor immunity following allogeneic stem cell transplantation (English)

1 reference

14 August 2017

Catherine J Wu

1

1 reference

14 August 2017

Jerome Ritz

series ordinal

2

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

published in

Advances in Immunology

1 reference

14 August 2017

volume

90

1 reference

14 August 2017

page(s)

133-173

1 reference

Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Fc gamma receptors and cross-presentation in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Molecules and mechanisms of the graft-versus-leukaemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Characterization of single-nucleotide polymorphisms in coding regions of human genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Coordination of activating and inhibitory signals in natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identification of a graft versus host disease-associated human minor histocompatibility antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplan

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Chimaeric cultures of human marrow stroma and murine leukaemia cells: evidence for abnormalities in the haemopoietic microenvironment in myeloid malignancies and other infiltrating marrow disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The human Y chromosome: overlapping DNA clones spanning the euchromatic region

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Pattern of T cell reconstitution following allogeneic bone marrow transplantation for acute hematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Age-dependent incidence, time course, and consequences of thymic renewal in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Immunotherapy of cancer through targeting of minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identification of APOBEC3B as a potential target for the graft-versus-lymphoma effect by SEREX in a patient with mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

1 reference

7 January 2021

Determinants of antileukemia effects of allogeneic NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Antigen-specific development of primary and memory T cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Unravelling natural killer cell function: triggering and inhibitory human NK receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

A human minor histocompatibility antigen resulting from differential expression due to a gene deletion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Allogeneic transplantation of CD34+ selected hematopoietic cells--clinical problems and current challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identification of novel survivin-derived CTL epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Finding a place for tumor-specific T cells in targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The complete 685-kilobase DNA sequence of the human beta T cell receptor locus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Natural killer cell alloreactivity for leukemia therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Serological identification of human tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Minor histocompatibility antigens as targets for T-cell therapy after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990004-2

7 January 2021

10.1016/S0065-2776(06)90004-2

Identifiers

DOI

1 reference

14 August 2017

1 reference